These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
401 related items for PubMed ID: 15829701
1. Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells. Hernández-Vargas P, López-Franco O, Sanjuán G, Rupérez M, Ortiz-Muñoz G, Suzuki Y, Aguado-Roncero P, Pérez-Tejerizo G, Blanco J, Egido J, Ruiz-Ortega M, Gómez-Guerrero C. J Am Soc Nephrol; 2005 Jun; 16(6):1673-83. PubMed ID: 15829701 [Abstract] [Full Text] [Related]
2. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli. Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB. Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947 [Abstract] [Full Text] [Related]
3. Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury. Gómez-Guerrero C, López-Franco O, Sanjuán G, Hernández-Vargas P, Suzuki Y, Ortiz-Muñoz G, Blanco J, Egido J. J Immunol; 2004 Jun 01; 172(11):6969-77. PubMed ID: 15153517 [Abstract] [Full Text] [Related]
4. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. Rico-Bautista E, Negrín-Martínez C, Novoa-Mogollón J, Fernández-Perez L, Flores-Morales A. Exp Cell Res; 2004 Mar 10; 294(1):269-80. PubMed ID: 14980520 [Abstract] [Full Text] [Related]
5. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. McWhinney CD, Dostal D, Baker K. J Mol Cell Cardiol; 1998 Apr 10; 30(4):751-61. PubMed ID: 9602424 [Abstract] [Full Text] [Related]
6. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells. Huang JS, Guh JY, Hung WC, Yang ML, Lai YH, Chen HC, Chuang LY. Biochem J; 1999 Aug 15; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321 [Abstract] [Full Text] [Related]
7. Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway. Wang TL, Yang YH, Chang H, Hung CR. J Mol Cell Cardiol; 2004 Sep 15; 37(3):785-94. PubMed ID: 15350851 [Abstract] [Full Text] [Related]
8. Two Drosophila suppressors of cytokine signaling (SOCS) differentially regulate JAK and EGFR pathway activities. Rawlings JS, Rennebeck G, Harrison SM, Xi R, Harrison DA. BMC Cell Biol; 2004 Oct 15; 5(1):38. PubMed ID: 15488148 [Abstract] [Full Text] [Related]
9. Differential regulation of Toll-like receptor 4 gene expression in renal cells by angiotensin II: dependency on AP1 and PU.1 transcriptional sites. Bondeva T, Roger T, Wolf G. Am J Nephrol; 2007 Oct 15; 27(3):308-14. PubMed ID: 17495427 [Abstract] [Full Text] [Related]
10. The Jak-STAT pathway stimulated by interferon gamma. Horvath CM. Sci STKE; 2004 Nov 23; 2004(260):tr8. PubMed ID: 15561980 [Abstract] [Full Text] [Related]
11. JAK/STAT signal transduction: regulators and implication in hematological malignancies. Valentino L, Pierre J. Biochem Pharmacol; 2006 Mar 14; 71(6):713-21. PubMed ID: 16426581 [Abstract] [Full Text] [Related]
12. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway. Park ES, Kim H, Suh JM, Park SJ, You SH, Chung HK, Lee KW, Kwon OY, Cho BY, Kim YK, Ro HK, Chung J, Shong M. Mol Endocrinol; 2000 May 14; 14(5):662-70. PubMed ID: 10809230 [Abstract] [Full Text] [Related]
13. A family of cytokine-inducible inhibitors of signalling. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. Nature; 1997 Jun 26; 387(6636):917-21. PubMed ID: 9202125 [Abstract] [Full Text] [Related]
14. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways. Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, McWhinney CD, Baker KM. J Mol Cell Cardiol; 1997 Nov 26; 29(11):2893-902. PubMed ID: 9405164 [Abstract] [Full Text] [Related]
15. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems. Calegari VC, Alves M, Picardi PK, Inoue RY, Franchini KG, Saad MJ, Velloso LA. Endocrinology; 2005 Feb 26; 146(2):579-88. PubMed ID: 15514089 [Abstract] [Full Text] [Related]
16. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB. Kidney Int; 2002 May 26; 61(5):1605-16. PubMed ID: 11967010 [Abstract] [Full Text] [Related]
17. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Nature; 1995 May 18; 375(6528):247-50. PubMed ID: 7746328 [Abstract] [Full Text] [Related]
18. Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis. Zhang SL, Guo J, Moini B, Ingelfinger JR. Kidney Int; 2004 Dec 18; 66(6):2181-92. PubMed ID: 15569307 [Abstract] [Full Text] [Related]
19. Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 is involved in gp130 resistance in cardiovascular system in rat treated with cardiotrophin-1 in vivo. Hamanaka I, Saito Y, Yasukawa H, Kishimoto I, Kuwahara K, Miyamoto Y, Harada M, Ogawa E, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Masuda I, Yoshimura A, Nakao K. Circ Res; 2001 Apr 13; 88(7):727-32. PubMed ID: 11304496 [Abstract] [Full Text] [Related]
20. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Schieffer B, Luchtefeld M, Braun S, Hilfiker A, Hilfiker-Kleiner D, Drexler H. Circ Res; 2000 Dec 08; 87(12):1195-201. PubMed ID: 11110778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]